GLP-1 receptor agonists (semaglutide) and dual GLP-1/GIP receptor agonists (tirzepatide) do not directly cause muscle wasting
In contrast to this result, another recent study by Kovarik et al
Although the Court upheld prima facie invalidity of Novos patent over semaglutide, the DHC granted Novo an interim injunction, alleging that Defendants have failed to clear the way before they started manufacturing, which showed their procedural mala fide., preventing the Indian companies from selling or marketing semaglutide within India until March 20th 2026
Seit kurzem sind rzte in Deutschland in der Lage, ihren an Adipositas leidenden Patienten in Sachen Lebensstil-Interventionen sehr unkompliziert Untersttzung auf Rezept an die Hand zu geben: Oviva ist seit 2023 vom BfArM dauerhaft als digitale Gesundheitsanwendung gelistet und damit verordnungsfhig
No commitment involved, just a sincere conversation on whether this would be a good fit for you
Under IRS Publication 502 and Section 213 of the tax code, a medical expense is deductible only when it's used for the "diagnosis, cure, mitigation, treatment, or prevention of disease." In 2024, the IRS issued guidance (FS-2024-07) reaffirming this framework for GLP-1 medications specifically